{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:57:17Z","timestamp":1780966637628,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.arr.2010.02.005","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T07:26:36Z","timestamp":1268205996000},"page":"265-268","source":"Crossref","is-referenced-by-count":27,"title":["Mechanistic contribution of carnitine deficiency to geriatric frailty"],"prefix":"10.1016","volume":"9","author":[{"given":"Victor","family":"Crentsil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2010.02.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-9120(87)80090-5","article-title":"Clinical varieties of carnitine and carnitine palmitoyltransferase deficiency","volume":"20","author":"Angelini","year":"1987","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.arr.2010.02.005_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/bmme.1997.2647","article-title":"Qualitative and quantitative changes in skeletal muscle mtDNA and expression of mitochondrial-encoded genes in the human aging process","volume":"62","author":"Barrientos","year":"1997","journal-title":"Biochem. Mol. Med."},{"key":"10.1016\/j.arr.2010.02.005_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/mgme.1999.2938","article-title":"Carnitine palmitoyltransferase deficiencies","volume":"68","author":"Bonnefont","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.arr.2010.02.005_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ajcn\/43.1.85","article-title":"Plasma carnitine levels in patients receiving home parenteral nutrition","volume":"43","author":"Bowyer","year":"1986","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.arr.2010.02.005_bib5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0272-6386(05)80019-8","article-title":"Intravenous l-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients","volume":"37","author":"Brass","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.arr.2010.02.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-0690(18)30494-4","article-title":"Preventing frail health","volume":"8","author":"Buchner","year":"1992","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.arr.2010.02.005_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jnutbio.2005.03.027","article-title":"Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genes","volume":"17","author":"Calabrese","year":"2006","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.arr.2010.02.005_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mus.880160713","article-title":"Muscle carnitine deficiency and lipid storage myopathy in patients with mitochondrial myopathy","volume":"16","author":"Campos","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arr.2010.02.005_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mus.880160205","article-title":"Plasma carnitine insufficiency and effectiveness of l-carnitine therapy in patients with mitochondrial myopathy","volume":"16","author":"Campos","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arr.2010.02.005_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/ard.54.6.491","article-title":"Respiratory chain enzyme deficiency in patients with idiopathic inflammatory myopathy","volume":"54","author":"Campos","year":"1995","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.arr.2010.02.005_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1096-7192(02)00169-5","article-title":"Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency","volume":"77","author":"Cederbaum","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.arr.2010.02.005_bib12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0006-291X(89)91360-0","article-title":"Age-dependent decrease of carnitine content in muscle of mice and humans","volume":"161","author":"Costell","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2010.02.005_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.arr.2006.03.002","article-title":"Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle","volume":"5","author":"Dirks","year":"2006","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2010.02.005_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/gerona\/62.7.744","article-title":"Frailty and the risk of falls, fracture, and mortality in older women: the study of osteoporosis fractures","volume":"62","author":"Ensrud","year":"2007","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2010.02.005_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1196\/annals.1320.012","article-title":"Carnitine and its congeners. A metabolic pathway to the regulation of immune response and inflammation","volume":"1033","author":"Famularo","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.arr.2010.02.005_bib16","first-page":"53","article-title":"Immunological parameters in aging: studies on natural immunomodulatory and immunoprotective substances","volume":"10","author":"Franceschi","year":"1990","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"10.1016\/j.arr.2010.02.005_bib17","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2010.02.005_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","article-title":"Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care","volume":"59","author":"Fried","year":"2004","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2010.02.005_bib19","first-page":"2229","article-title":"Muscle dysfunction in elderly individuals with hip fracture","volume":"26","author":"Gonzalez-Crespo","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.arr.2010.02.005_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002280050504","article-title":"Increased urinary excretion of carnitine in patients treated with cisplatin","volume":"54","author":"Heuberger","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2010.02.005_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1196\/annals.1320.002","article-title":"Structure and function of carnitine acyltransferases","volume":"1033","author":"Jogl","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.arr.2010.02.005_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/15216540500097111","article-title":"From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance","volume":"57","author":"Karin","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.arr.2010.02.005_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00109-003-0447-6","article-title":"Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes","volume":"81","author":"Karlic","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.arr.2010.02.005_bib24","first-page":"105","article-title":"Primary carnitine deficiency in a male adult","volume":"33","author":"Karmaniolas","year":"2002","journal-title":"J. Med."},{"key":"10.1016\/j.arr.2010.02.005_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/03610730590882846","article-title":"Supplementation of l-carnitine improves mitochondrial enzymes in heart and skeletal muscle of aged rats","volume":"31","author":"Kumaran","year":"2005","journal-title":"Exp. Aging Res."},{"key":"10.1016\/j.arr.2010.02.005_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03324545","article-title":"Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty","volume":"16","author":"Leng","year":"2004","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.arr.2010.02.005_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.smj.0000203331.26947.47","article-title":"l-Carnitine reduces severity of physical and mental fatigue and improves daily activities in the elderly","volume":"3","author":"Malaguarnera","year":"2006","journal-title":"South Med. J."},{"key":"10.1016\/j.arr.2010.02.005_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0009-8981(76)90532-5","article-title":"The relationship between serum carnitine levels and the nutritional status of patients with schistosomiasis","volume":"71","author":"Mikhail","year":"1976","journal-title":"Clin. Chim. Acta"},{"issue":"Suppl: S","key":"10.1016\/j.arr.2010.02.005_bib29","first-page":"40","article-title":"Carnitine in human immunodeficiency virus type 1 infection\/acquired immune deficiency syndrome","volume":"10","author":"Mintz","year":"1995","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.arr.2010.02.005_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.jrn.2004.09.031","article-title":"Inflammation and carnitine in hemodialysis patients","volume":"15","author":"Pertosa","year":"2005","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.arr.2010.02.005_bib31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00002512-200320100-00004","article-title":"Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue","volume":"20","author":"Pistone","year":"2003","journal-title":"Drugs Aging"},{"issue":"Suppl 2","key":"10.1016\/j.arr.2010.02.005_bib32","first-page":"S8","article-title":"Primary and secondary carnitine deficiency syndromes","volume":"10","author":"Pons","year":"1995","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.arr.2010.02.005_bib33","first-page":"533","article-title":"Carnitine metabolism and deficiency syndromes","volume":"58","author":"Rebouche","year":"1983","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.arr.2010.02.005_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.nu.06.070186.000353","article-title":"Carnitine metabolism and function in humans","volume":"6","author":"Rebouche","year":"1986","journal-title":"Ann. Rev. Nutr."},{"key":"10.1016\/j.arr.2010.02.005_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.jrn.2004.10.002","article-title":"l-Carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients","volume":"15","author":"Savica","year":"2005","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.arr.2010.02.005_bib36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.clnu.2005.04.005","article-title":"Efficacy of levo carnitine and alpha lipoic acid in ameliorating the decline in mitochondrial enzymes during aging","volume":"24","author":"Savitha","year":"2005","journal-title":"Clin. Nutr."},{"issue":"Part 2","key":"10.1016\/j.arr.2010.02.005_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1113\/jphysiol.2006.125799","article-title":"New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle","volume":"581","author":"Stephens","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.arr.2010.02.005_bib38","first-page":"246","article-title":"Carnitine metabolism and human carnitine deficiency","volume":"9","author":"Tanphaichitr","year":"1993","journal-title":"Nutrition"},{"key":"10.1016\/j.arr.2010.02.005_bib39","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1124\/mol.106.028126","article-title":"Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5)","volume":"70","author":"Urban","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.arr.2010.02.005_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/S0026-0495(03)00297-X","article-title":"Frailty in the elderly: contributions of sarcopenia and visceral protein depletion","volume":"52","author":"Vanitallie","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.arr.2010.02.005_bib41","doi-asserted-by":"crossref","first-page":"C802","DOI":"10.1152\/ajpcell.00046.2002","article-title":"l-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure","volume":"283","author":"Vescovo","year":"2002","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.arr.2010.02.005_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejim.2005.02.014","article-title":"Serum carnitine levels in patients with tumoral cachexia","volume":"16","author":"Vinci","year":"2005","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.arr.2010.02.005_bib43","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1001\/archinte.162.20.2333","article-title":"Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study","volume":"162","author":"Walston","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.arr.2010.02.005_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1536\/ihj.36.319","article-title":"Effects of l- and dl-carnitine on patients with impaired exercise tolerance","volume":"36","author":"Watanabe","year":"1995","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.arr.2010.02.005_bib45","first-page":"165","article-title":"Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity","volume":"21","author":"Yaris","year":"2002","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163710000218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163710000218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T17:05:05Z","timestamp":1558890305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163710000218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1568163710000218"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2010.02.005","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}